Preclinical Evaluation of an Anti-EphA2 Minibody-Based ImmunoPET Agent as a Diagnostic Tool For Cancer. - Birikorang PA; Wedaarachchi HEG; Smith JA; Kohanbash G; Edwards WB (Molecular imaging and biology, 2025)